期刊文献+

血清儿茶酚抑素和半乳糖凝集素-3联合检测对急性失代偿性心力衰竭患者短期预后的评估价值 被引量:1

Value of combined detection of serum CST and Gal-3 in evaluating short-term prognosis of patients with acute decompensated heart failure after discharge
原文传递
导出
摘要 目的:探讨血清儿茶酚抑素(CST)、半乳糖凝集素-3(Gal-3)联合检测对急性失代偿性心力衰竭(ADHF)患者出院后短期预后的评估价值。方法:采用前瞻性研究方法,选择2019年1月5日-2021年8月30日期间我院收治的ADHF患者为病例组,另选择同期在我院体检健康的志愿者98例为对照组,对比病例组患者入院时、对照组体检时血清CST、Gal-3水平。根据患者出院后30 d内是否出现不良事件将其分为预后不良组(因心力衰竭再入院或全因死亡)与预后良好组,对比预后不良组、预后良好组患者的临床资料、实验室指标和入院时血清CST、Gal-3水平,分析ADHF患者出院后短期内发生不良事件的危险因素,分析部分指标及联合检测对ADHF患者出院后短期内发生不良事件的预测价值。结果:病例组患者入院时血清CST、Gal-3水平显著高于对照组(P<0.05);预后不良组患者的美国纽约心脏病学会(NYHA)心功能分级Ⅳ级比例及血清N末端B型利钠肽原(NT-proBNP)、CST、Gal-3水平均显著高于预后良好组(P<0.05),左心室射血分数(LVEF)显著低于预后良好组(P<0.05)。Logistic回归分析显示,LVEF降低、NT-proBNP升高、CST升高、Gal-3升高是患者出院后短期内不良事件发生的危险因素(P<0.05)。受试者工作特征(ROC)曲线分析显示,联合检测患者出院后短期内发生不良事件的曲线下面积(AUC)为0.859、敏感度为0.833,特异度为0.883。结论:血清CST和Gal-3是ADHF患者出院后短期不良预后的危险因素,检测入院时血清CST、Gal-3水平有助于预测患者出院后短期不良预后,联合检测的预测价值更高。 Objective:To investigate the value of combined detection of serum catechinstatin(CST)and galectin-3(Gal-3)in evaluating short-term prognosis of patients with acute decompensated heart failure(ADHF)after discharge.Methods:Using the prospective research method,patients with ADHF treated in the people’s hospital of Inner Mongolia Autonomous Region from January 5,2019 to August 30,2021 were selected as the case group,and 98 healthy volunteers who underwent physical examination in our hospital in the same period were included in the control group.The levels of serum CST and Gal-3 in the case group at admission and in the control group at physical examination were compared.According to whether there were adverse events within 30 days after discharge,the patients were divided into poor prognosis group(readmission due to heart failure or all-cause death)and good prognosis group.The clinical data,laboratory indexes,serum CST and Gal-3 levels at admission of patients in poor prognosis group and good prognosis group were compared,the risk factors of adverse events in a short time after discharge of ADHF patients were analyzed,and the serum CST The predictive value of Gal-3 level for adverse events in the short term after discharge in patients with ADHF.Results:The levels of serum CST and Gal-3 in the case group at admission were significantly higher than those in the control group(P<0.05).The proportion of New York Heart Association(NYHA)cardiac function classification was grade IV and the levels of serum N-terminal pro-B-type natriuretic peptide(NT-proBNP),CST and Gal-3 in the poor prognosis group were significantly higher than those in the good prognosis group(P<0.05),and the left ventricular ejection fraction(LVEF)was significantly lower than that in the good prognosis group(P<0.05).logistic regression analysis showed that the decrease of LVEF,the increase of NT-proBNP,CST,Gal-3 were the risk factors of adverse events in the short term of patients(P<0.05).The receiver operating characteristic(ROC)curve analysis showed that the area under curve(AUC)of combined prediction for short-term adverse events after discharge was 0.859,the sensitivity was 0.833,and the specificity was 0.883.Conclusion:Serum CST and Gal-3 are risk factors for short-term poor prognosis in patients with ADHF after discharge.Detecting the levels of serum CST and Gal-3 at admission is helpful to predict the short-term poor prognosis after discharge,and the predictive value of combined detection is higher.
作者 王佳乐 赵兴胜 吴云 WANG Jiale;ZHAO Xingsheng;WU Yun(Department of Internal Medicine-Cardiovascular,Peoples Hospital of Inner Mongolia Autonomous Region,Hohhot,Inner Mongolia,010020,China)
出处 《临床急诊杂志》 CAS 2022年第6期425-430,共6页 Journal of Clinical Emergency
基金 2019年内蒙古自治区卫生和计划生育委员会科研计划项目(No:nwjkj2019-1-008)。
关键词 儿茶酚抑素 半乳糖凝集素-3 急性失代偿性心力衰竭 预后 catecholastatin galectin-3 acute decompensated heart failure prognosis
  • 相关文献

参考文献18

二级参考文献156

  • 1托伐普坦临床研究协作组,张健,朱文玲.常规治疗基础上联用托伐普坦片治疗心原性水肿的有效性和安全性的多中心随机、双盲、安慰剂对照研究[J].中华心力衰竭和心肌病杂志(中英文),2017,1(1):15-21. 被引量:26
  • 2张维忠.高血压与左心室肥厚[J].临床心血管病杂志,1993,9(6):323-325. 被引量:69
  • 3Barondes SH,Cooper DNW,Gitt MA,et al. Galectins: structure and function of a large family of animal lectins[J]. J Biol Chem,1994,269 (33):20807-10.
  • 4Kim H,Lee J,Hyun JW,et al. Expression and immunohistochemical localization of Galectin-3 in various mouse tissues[J]. Cell Biol Int,2007,31 (7):655-62.
  • 5Elola MT,Wolfenstein-Todel C,Troncoso MF,et al. Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival[J]. Cell Mol Life Sci,2007,64(13): 1679-700.
  • 6Nakahara S,Oka N,Wang Y,et al. Characterization of the nuclear import pathways of Galectin-3[J]. Cancer Res,2006,66(20):9995-10006.
  • 7van Kimmenade RR,Januzzi JL Jr,Ellinor PT,et al. Utility of amino- terminal pro-brain natriuretic peptide, Galectin-3, and apelin for the evaluation of patients with acute heart failure[J]. J Am Coll Cardiol, 2006,48(6): 1217-24.
  • 8Sharma UC,Pokharel S,van Brakel TJ,et al. Galeetin-3 marks activated maerophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction[J]. Circulation,2004,110( 19):3121-8.
  • 9Henderson NC,Maekinnon AC,Farnworth SL,et al. Galeetin-3 regulates myofibroblast activation and hepatic fibrosis[J]. Proe Natl Aead Sci USA,2006,103(13):5060-5.
  • 10Thandavarayan RA,Watanabe K,Ma M,et al. 14-3-3 protein regulates Askl signaling and protects against diabetic cardiomyopathy[J]. Biochem Pharmacol,2008,75(9): 1797-806.

共引文献974

同被引文献6

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部